The Power of Innovation: How Technology Facilitates Market & Patient Access

FiercePharma sits down with the President of Xcenda, Kristine Flemister, to discuss how technology is helping to commercialize new therapies, develop value propositions and expand market access.

Read more on

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.